Martina Zaninotto
Overview
Explore the profile of Martina Zaninotto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
1529
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zaninotto M, Agnello L, Dukic L, Salek T, Linko-Parvinen A, Kalaria T, et al.
Clin Chem Lab Med
. 2025 Feb;
PMID: 39963968
The ultimate goal of harmonization, crucial to quality in laboratory medicine, is to improve patient outcomes by providing accurate, actionable laboratory information. Patients and healthcare professionals assume that clinical laboratory...
2.
Clerico A, Zaninotto M, Aimo A, Padoan A, Passino C, Fortunato A, et al.
Clin Chem Lab Med
. 2025 Feb;
PMID: 39915924
Although significant progress has been made in recent years, some important questions remain regarding the analytical performance, pathophysiological interpretation and clinical use of cardiac troponin I (cTnI) and T (cTnT)...
3.
Talli I, Marchioro L, Zaninotto M, Cosma C, Pangrazzi E, Artusi C, et al.
Clin Chim Acta
. 2025 Feb;
569:120158.
PMID: 39892693
Pyridoxal-5'-Phosphate (PLP) is not always added to the reagents for the measurement of Aspartate Amino Transferase (AST) and Alanine Amino Transferase (ALT), although the International Federation of Clinical Chemistry recommends...
4.
Cosma C, Talli I, Pangrazzi E, Padoan A, Cerutti H, Zaninotto M, et al.
Clin Chem Lab Med
. 2025 Jan;
PMID: 39819746
Objectives: Mutations in the gene encoded glycoprotein progranulin (PGRN), cause 5-10 % of all cases of frontotemporal lobar degeneration (FTLD). The aim of our study was to verify the analytical...
5.
Musso G, Gabelli C, Cagnin A, Cosma C, Cecchin D, Zorzi G, et al.
Clin Chem Lab Med
. 2024 Nov;
63(4):e113-e116.
PMID: 39530774
No abstract available.
6.
Bertoldo F, Tripepi G, Zaninotto M, Plebani M, Scillitani A, Varenna M, et al.
J Bone Miner Res
. 2024 Nov;
40(1):79-86.
PMID: 39498489
Hypophosphatasia (HPP) is a rare disorder of the bone metabolism, characterized by genetically determined low alkaline phosphatase (ALP) activity. Low ALP may also be observed in some common causes of...
7.
Giannini S, Pitino A, Sella S, Fusaro M, Arcidiacono G, Torres M, et al.
Arch Osteoporos
. 2024 Oct;
19(1):105.
PMID: 39477860
Purpose: Vitamin D deficiency has been linked to negative health outcomes that extend beyond bone-related conditions. The frequency of vitamin D blood testing in residents from the Padua province, (Veneto,...
8.
Musso G, Gabelli C, Puthenparampil M, Cosma C, Cagnin A, Gallo P, et al.
Clin Chim Acta
. 2024 Oct;
565:120014.
PMID: 39442787
Background: Advances in analytical methods have recently paved the way to Alzheimer's disease (AD) biomarkers testing in blood along with the more established CSF testing. To ensure a forthcoming application...
9.
Fusaro M, Aghi A, Marino C, Mallamaci F, Plebani M, Zaninotto M, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407947
Chronic kidney disease and mineral bone disorders (CKD-MBD) are frequently associated with an increased risk of both vascular calcifications (VCs) and bone fractures (BFs). The complex pathogenesis of VCs and...
10.
Paolillo S, Graziani M, Indolfi C, Zaninotto M, Calabro P, Ceriotti F, et al.
G Ital Cardiol (Rome)
. 2024 Sep;
25(10):756-762.
PMID: 39342561
Dyslipidemia is one of the most important risk factors for the development of atherosclerotic disease and its control, through well-proven therapies, allows an optimal risk management over time. LDL-cholesterol targets...